Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

MBRX holding history

Moleculin Biotech, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MBRX overviewAll 13F holders of MBRXFull Q2 2026 holdings

Shares (Q2 2026)
20,036
Value
$55.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MBRX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,036$55.9K<0.1%+20,000+55,555.6%AddedHolders
Q1 202636$83<0.1%00.0%UnchangedHolders
Q4 202536$119<0.1%−1−2.8%ReducedConverted for a 1-for-25 splitHolders
Q3 2025926$491<0.1%00.0%UnchangedHolders
Q2 2025926$280<0.1%00.0%UnchangedHolders
Q1 2025926$901<0.1%+500+117.4%AddedHolders
Q4 2024426$724<0.1%−23−5.1%ReducedHolders
Q3 2024449$1.27K<0.1%+23+5.4%AddedHolders
Q2 2024426$1.50K<0.1%+3+0.7%AddedHolders
Q1 2024423$2.50K<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q4 20236,334$5.44K<0.1%00.0%UnchangedHolders
Q3 20236,334$2.71K<0.1%00.0%UnchangedHolders
Q2 20236,334$3.67K<0.1%00.0%UnchangedHolders
Q1 20236,334$6.08K<0.1%−5−0.1%ReducedHolders
Q4 20226,339$6.72K<0.1%+327+5.4%AddedHolders
Q3 20226,012$6.00K<0.1%+12+0.2%AddedHolders
Q2 20226,000$9.00K<0.1%−25−0.4%ReducedHolders
Q1 20226,025$11.0K<0.1%+24+0.4%AddedHolders
Q4 20216,001$11.0K<0.1%+10.0%AddedHolders
Q3 20216,000$18.0K<0.1%−3,713−38.2%ReducedHolders
Q2 20219,713$36.0K<0.1%00.0%UnchangedHolders
Q1 20219,713$39.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.